Boonphiphop Boonpheng1, Patompong Ungprasert2,3. 1. Department of Internal Medicine, East Tennessee State University, Johnson City, TN, USA. 2. Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. 3. Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abstract
Background: Recent studies have suggested that patients with idiopathic pulmonary fibrosis (IPF) may have a higher risk of venous thromboembolism (VTE) compared to general population even though the results were inconsistent. Objective: To investigate the risk of VTE among patients with IPF. Methods: Comprehensive literature review using MEDLINE and EMBASE database were performed to identify studies that compared the risk of VTE among patients with IPF to general population. Effect estimates from each study were combined together using random effect model, generic inverse variance method of DerSimonian and Laird. Results: Out of 510 retrieved articles, 5 studies met the inclusion criteria and were included in the meta-analysis. A significant risk of VTE in patients with IPF was observed with the pooled risk ratio of 2.11 (95% confidence interval, 1.28-3.48). The heterogeneity was moderate with I2 of 64%. Conclusion: An approximately 2-fold increased risk of VTE among patients with IPF was observed in this meta-analysis. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 109-114). Copyright:
Background: Recent studies have suggested that patients with idiopathic pulmonary fibrosis (IPF) may have a higher risk of venous thromboembolism (VTE) compared to general population even though the results were inconsistent. Objective: To investigate the risk of VTE among patients with IPF. Methods: Comprehensive literature review using MEDLINE and EMBASE database were performed to identify studies that compared the risk of VTE among patients with IPF to general population. Effect estimates from each study were combined together using random effect model, generic inverse variance method of DerSimonian and Laird. Results: Out of 510 retrieved articles, 5 studies met the inclusion criteria and were included in the meta-analysis. A significant risk of VTE in patients with IPF was observed with the pooled risk ratio of 2.11 (95% confidence interval, 1.28-3.48). The heterogeneity was moderate with I2 of 64%. Conclusion: An approximately 2-fold increased risk of VTE among patients with IPF was observed in this meta-analysis. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 109-114). Copyright:
Authors: Ganesh Raghu; Bram Rochwerg; Yuan Zhang; Carlos A Cuello Garcia; Arata Azuma; Juergen Behr; Jan L Brozek; Harold R Collard; William Cunningham; Sakae Homma; Takeshi Johkoh; Fernando J Martinez; Jeffrey Myers; Shandra L Protzko; Luca Richeldi; David Rind; Moisés Selman; Arthur Theodore; Athol U Wells; Henk Hoogsteden; Holger J Schünemann Journal: Am J Respir Crit Care Med Date: 2015-07-15 Impact factor: 21.405
Authors: William Dalleywater; Helen A Powell; Andrew W Fogarty; Richard B Hubbard; Vidya Navaratnam Journal: Eur Respir J Date: 2014-10-16 Impact factor: 16.671
Authors: D B Sprunger; A L Olson; T J Huie; E R Fernandez-Perez; A Fischer; J J Solomon; K K Brown; J J Swigris Journal: Eur Respir J Date: 2011-07-07 Impact factor: 16.671
Authors: B van Zaane; E Nur; A Squizzato; V E A Gerdes; H R Büller; O M Dekkers; D P M Brandjes Journal: J Thromb Haemost Date: 2010-11 Impact factor: 5.824
Authors: Richard B Hubbard; Chris Smith; Ivan Le Jeune; Jonathan Gribbin; Andrew W Fogarty Journal: Am J Respir Crit Care Med Date: 2008-08-28 Impact factor: 21.405
Authors: Vidya Navaratnam; Andrew W Fogarty; Tricia McKeever; Norma Thompson; Gisli Jenkins; Simon R Johnson; Gerard Dolan; Maruti Kumaran; Kate Pointon; Richard B Hubbard Journal: Thorax Date: 2013-09-03 Impact factor: 9.139